JGIA
GILD icon

Jackson Grant Investment Advisers’s Gilead Sciences GILD Stock Holding History

Jackson Grant Investment Advisers’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$131K Sell
1,035
-72
-7% -$9.49K 0.04% 151
2026
Q1 		$154K Hold
1,107
– – 0.05% 136
2025
Q4 		$136K Buy
1,107
+1
+0.1% +$122 0.04% 140
2025
Q3 		$123K Buy
1,106
+1
+0.1% +$114 0.04% 147
2025
Q2 		$122K Buy
1,105
+1
+0.1% +$106 0.05% 135
2025
Q1 		$124K Buy
1,104
+1
+0.1% +$103 0.05% 132
2024
Q4 		$102K Buy
1,103
+1
+0.1% +$90 0.04% 141
2024
Q3 		$92.4K Buy
1,102
+2
+0.2% +$153 0.03% 149
2024
Q2 		$75.5K Buy
1,100
+136
+14% +$9.08K 0.03% 152
2024
Q1 		$70.6K Hold
964
– – 0.03% 153
2023
Q4 		$78.1K Hold
964
– – 0.03% 149
2023
Q3 		$72.2K Sell
964
-67
-6% -$5.15K 0.03% 150
2023
Q2 		$79.4K Hold
1,031
– – 0.04% 148
2023
Q1 		$85.5K Buy
1,031
+67
+7% +$5.55K 0.04% 148
2022
Q4 		$82.7K Hold
964
– – 0.04% 145
2022
Q3 		$59K Hold
964
– – 0.03% 163
2022
Q2 		$60K Hold
964
– – 0.03% 167
2022
Q1 		$57K Sell
964
-91
-9% -$5.82K 0.02% 184
2021
Q4 		$77K Hold
1,055
– – 0.04% 137
2021
Q3 		$74K Buy
1,055
+287
+37% +$20.2K 0.03% 174
2021
Q2 		$53K Buy
768
+19
+3% +$1.27K 0.02% 200
2021
Q1 		$48K Buy
749
+5
+0.7% +$322 0.02% 202
2020
Q4 		$43K Buy
744
+6
+0.8% +$362 0.02% 197
2020
Q3 		$47K Buy
738
+5
+0.7% +$347 0.03% 150
2020
Q2 		$56K Buy
733
+5
+0.7% +$383 0.04% 135
2020
Q1 		$54K Buy
728
+148
+26% +$10.2K 0.04% 133
2019
Q4 		$38K Sell
580
-251
-30% -$16.3K 0.02% 158
2019
Q3 		$53K Buy
831
+4
+0.5% +$261 0.03% 146
2019
Q2 		$56K Buy
827
+5
+0.6% +$329 0.03% 144
2019
Q1 		$53K Buy
822
+105
+15% +$6.98K 0.03% 141
2018
Q4 		$45K Buy
717
+260
+57% +$18.2K 0.03% 146
2018
Q3 		$35K Buy
457
+4
+0.9% +$302 0.02% 161
2018
Q2 		$32K Buy
453
+3
+0.7% +$212 0.02% 170
2018
Q1 		$34K Buy
450
+4
+0.9% +$318 0.02% 166
2017
Q4 		$32K Buy
446
+3
+0.7% +$228 0.02% 167
2017
Q3 		$36K Buy
443
+3
+0.7% +$229 0.03% 162
2017
Q2 		$31K Buy
440
+3
+0.7% +$200 0.02% 150
2017
Q1 		$30K Sell
437
-67
-13% -$4.71K 0.02% 143
2016
Q4 		$36K Buy
504
+3
+0.6% +$223 0.03% 135
2016
Q3 		$40K Sell
501
-57
-10% -$4.63K 0.03% 123
2016
Q2 		$47K Buy
558
+2
+0.4% +$177 0.04% 111
2016
Q1 		$51K Buy
556
+82
+17% +$7.39K 0.05% 101
2015
Q4 		$48K Buy
+474
New +$49.3K 0.05% 106

Other funds holding GILD

Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Jackson Grant Investment Advisers's GILD Position: Q2 2026 in Review

Jackson Grant Investment Advisers reduced its Gilead Sciences (GILD) stake by 6.5% in Q2 2026, selling an estimated $9.49K and leaving 1,035 shares worth $131K. The position accounts for 0.04% of the portfolio, ranked #151.

Jackson Grant Investment Advisers first reported a position in GILD in Q4 2015 and has held it in 43 quarters since. The position peaked at $154K in Q1 2026. 1,031 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Jackson Grant Investment Advisers held 1,035 shares of Gilead Sciences worth $131K as of Q2 2026.
  • Jackson Grant Investment Advisers sold 72 Gilead Sciences shares in Q2 2026, an estimated $9.49K.
  • Gilead Sciences made up 0.04% of Jackson Grant Investment Advisers's portfolio in Q2 2026, its #151 holding.
  • Jackson Grant Investment Advisers first reported a position in Gilead Sciences in Q4 2015 and has held it in 43 quarters since.
  • Jackson Grant Investment Advisers's Gilead Sciences position peaked at $154K in Q1 2026.
  • 1,031 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Jackson Grant Investment Advisers's 13F filing for Q2 2026, filed 31 Jul 2026.